21 April 2022 : Case report
A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem Cell Transplantation
Unusual clinical course, Unusual or unexpected effect of treatment
DOI: 10.12659/AJCR.935353
Am J Case Rep 2022; 23:e935353